bay y3118 has been researched along with imipenem, anhydrous in 1 studies
| Studies (bay y3118) | Trials (bay y3118) | Recent Studies (post-2010) (bay y3118) | Studies (imipenem, anhydrous) | Trials (imipenem, anhydrous) | Recent Studies (post-2010) (imipenem, anhydrous) |
|---|---|---|---|---|---|
| 37 | 0 | 0 | 4,784 | 391 | 1,397 |
| Protein | Taxonomy | bay y3118 (IC50) | imipenem, anhydrous (IC50) |
|---|---|---|---|
| Beta-lactamase | Pseudomonas aeruginosa | 0.15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fresnadillo-Martínez, MJ; García-García, MI; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Trujillano-Martín, I | 1 |
1 other study(ies) available for bay y3118 and imipenem, anhydrous
| Article | Year |
|---|---|
In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoxitin; Chloramphenicol; Clindamycin; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Quinolones | 1995 |